Circular RNA and Its Roles in the Occurrence, Development, Diagnosis of Cancer

Yue Zhang1, Xinyi Zhang1, Yumeng Xu1

  • 1Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.

Frontiers in Oncology
|April 25, 2022
PubMed

Insights

Circular RNAs (circRNAs) are stable molecules involved in biological events, including cancer. This review details circRNA functions and their potential as cancer biomarkers for diagnosis and treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) are non-coding RNAs with high abundance, specificity, and stability.
  • They are primarily formed through the reverse splicing of precursor mRNAs.
  • circRNAs play crucial roles in various biological processes, notably in cancer development.

Purpose of the Study:

  • To review the classification, characterization, biogenesis, and functions of circRNAs.
  • To highlight the latest advancements in circRNA research concerning cancer.
  • To explore the potential of circRNAs as biomarkers for cancer diagnosis and therapy.

Main Methods:

  • Literature review of existing studies on circRNAs and cancer.
  • Analysis of circRNA classification, biogenesis pathways, and functional mechanisms.
  • Synthesis of current findings on circRNAs in cancer research and biomarker development.

Main Results:

  • circRNAs exhibit diverse functions and mechanisms relevant to biological events, including cancer.
  • Significant progress has been made in understanding circRNA roles in cancer occurrence and progression.
  • circRNAs show promise as novel biomarkers for cancer detection and treatment strategies.

Conclusions:

  • circRNAs are critical regulators in biological systems and disease.
  • Further research into circRNAs offers new avenues for cancer diagnostics and therapeutics.
  • The stability and specificity of circRNAs make them valuable targets for future studies.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K